OTC Pharmaceuticals - Egypt

  • Egypt
  • Revenue in the OTC Pharmaceuticals market amounts to €1,376.00m in 2024. The market is expected to grow annually by 11.11% (CAGR 2024-2029).
  • The market's largest segment is the segment Vitamins & Minerals with a market volume of €489.40m in 2024.
  • In global comparison, most revenue is generated in the United States (€37,850m in 2024).
  • In relation to total population figures, per person revenues of €12.02 are generated in 2024.
  • In the OTC Pharmaceuticals market, 8.5% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Mercado
 
Región
 
Comparación de regiones
 
Moneda
 

Analyst Opinion

The OTC Pharmaceuticals market in Egypt has been experiencing significant growth in recent years, driven by a combination of customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in Egypt have shifted towards self-medication and convenience, leading to an increased demand for over-the-counter (OTC) pharmaceuticals.

Consumers are increasingly seeking quick and easy solutions for minor health issues, such as headaches, colds, and allergies. This preference for self-medication is driven by factors such as affordability, accessibility, and the desire to avoid the hassle of visiting a doctor for minor ailments. In line with global trends, the OTC Pharmaceuticals market in Egypt has witnessed a rise in the availability and variety of OTC products.

This is due to advancements in pharmaceutical research and development, which have led to the introduction of new and innovative OTC medications. Additionally, the increasing prevalence of chronic diseases, such as diabetes and hypertension, has created a growing market for OTC medications that help manage these conditions. Local special circumstances in Egypt have also contributed to the development of the OTC Pharmaceuticals market.

The country has a large population, with a significant proportion of young and middle-aged individuals who are more likely to seek OTC solutions for minor health issues. Furthermore, Egypt has a well-established retail sector, with pharmacies and drugstores readily accessible to consumers across the country. This widespread availability of OTC products has further fueled the growth of the market.

Underlying macroeconomic factors have played a crucial role in the development of the OTC Pharmaceuticals market in Egypt. The country has experienced steady economic growth in recent years, resulting in an increase in disposable income levels. This has allowed consumers to allocate a larger portion of their budget towards healthcare, including OTC medications.

Additionally, the government has implemented healthcare reforms aimed at improving access to affordable healthcare services, which has further boosted the demand for OTC pharmaceuticals. In conclusion, the OTC Pharmaceuticals market in Egypt is developing due to customer preferences for self-medication and convenience, market trends towards increased availability and variety of OTC products, local special circumstances such as a large population and well-established retail sector, and underlying macroeconomic factors including economic growth and healthcare reforms.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Visión general

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Espere, por favor

Contacto

¿Alguna duda? Estaremos encantados de atenderte.
Statista Locations
Contacto Nerea Marcos
Nerea Marcos
Client Success Manager

Lu - vi, 9:30 - 17:00 h (CET)

Contacto Meredith Alda
Meredith Alda
Sales Manager– Contacto (Estados Unidos)

Lu - vi, 9:00 - 18:00 h (EST)

Contacto Yolanda Mega
Yolanda Mega
Operations Manager– Contacto (Asia)

Lu - vi, 9:00 - 17:00 h (SGT)

Contacto Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contacto (Asia)

Lu - vi, 10:00 - 18:00 h (JST)

Contacto Lodovica Biagi
Lodovica Biagi
Director of Operations– Contacto (Europa)

Lu - vi, 9:30 - 17:00 h (GMT)

Contacto Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contacto (América Latina)

Lu - vi, 9:00am-6:00pm (EST)